Precipio Inc Quick Ratio (PRPO) starting from the second quarter 2026 to second quarter 2025, Financial Strength Trends, Rankings, Financial Ratios - CSIMarket
CSIMarket
 


Precipio inc   (NASDAQ: PRPO)

Precipio Inc 's Quick Ratio

PRPO's quarterly Quick Ratio and Cash & cash equivalent, Current Liabilities growth


In the wake of the increase in Current Liabilities in the second quarter 2026, Quick Ratio fell to 0.83 below Precipio Inc average.

Within Laboratory Analytical Instruments industry 13 other companies have achieved higher Quick Ratio than Precipio Inc in second quarter 2026. While Quick Ratio total ranking in the second quarter 2026 has deteriorated compared to the prior quarter from 1677 to 1971.

Explain Quick Ratio?
How much Cash & cash equivalents PRPO´s has?
What are PRPO´s Current Liabilities?




PRPO Quick Ratio (Jun 30 2026)
Q2
(Mar 31 2026)
Q1
(Dec 31 2025)
Q4
(Sep 30 2025)
Q3
(Jun 30 2025)
Q2
Y / Y Current Liabilities Change 0.9 % -17.75 % -23.24 % -7.51 % -8.8 %
Y / Y Cash & cash equivalent Change 172.12 % 156.05 % 90.86 % 118.9 % -11.65 %
Quick Ratio MRQ 0.83 0.85 0.93 0.64 0.31
PRPO's Total Ranking # 1971 # 1677 # 1770 # 1777 # 2401
Seq. Current Liabilities Change 21.23 % 7.09 % -20.72 % -1.96 % -1.19 %
Seq. Cash & cash equivalent Change 18.09 % -1.77 % 15.01 % 103.98 % 11.11 %



Quick Ratio second quarter 2026 Company Ranking
Within: No.
Laboratory Analytical Instruments Industry # 14
Healthcare Sector # 660
Overall Market # 1971


Quick Ratio Statistics
High Average Low
16.51 1.05 0
(Jun 30 2019)   (Mar 31 2017)




Financial Statements
Precipio Inc 's Current Liabilities $ 4 Millions Visit PRPO's Balance sheet
Precipio Inc 's Cash & cash equivalent $ 3 Millions Visit PRPO's Balance sheet
Source of PRPO's Sales Visit PRPO's Sales by Geography


Cumulative Precipio Inc 's Quick Ratio

PRPO's Quick Ratio for the trailling 12 Months

PRPO Quick Ratio

(Jun 30 2026)
12 Months
(Mar 31 2026)
12 Months
(Dec 31 2025)
12 Months
(Sep 30 2025)
12 Months
(Jun 30 2025)
12 Months
Y / Y Current Liabilities TTM Growth -11.89 % -14.14 % -4.52 % 9.24 % 2.48 %
Y / Y Cash & cash equivalent TTM Growth 131.75 % 83.41 % 57.95 % 26.7 % -10.35 %
Quick Ratio TTM 0.81 0.66 0.51 0.4 0.31
Total Ranking TTM # 4047 # 2862 # 3102 # 3384 # 2866
Seq. Current Liabilities TTM Growth 0.25 % -4.77 % -5.87 % -1.95 % -2.31 %
Seq. Cash & cash equivalent TTM Growth 22.38 % 22.34 % 21.61 % 27.28 % -3.14 %


On the trailing twelve months basis PRPO Cash & cash equivalent more than doubled by 172.12 % in Q2 2026 year on year, faster than Current Liabilities, this led to increase in in Precipio Inc 's Quick Ratio to 0.81, Quick Ratio remained below PRPO average.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Laboratory Analytical Instruments industry 22 other companies have achieved higher Quick Ratio than Precipio Inc . While Quick Ratio total ranking has deteriorated compared to the previous twelve months ending in the first quarter 2026 from 2862 to 4047.

Explain Quick Ratio?
How much Cash & cash equivalents PRPO´s has?
What are PRPO´s Current Liabilities?

TTM Quick Ratio Company Ranking
Within: No.
Within the Laboratory Analytical Instruments Industry # 23
Healthcare Sector # 901
Within the Market # 4047


trailing twelve months Quick Ratio Statistics
High Average Low
6.78 1.07 0.01
(Sep 30 2019)   (Mar 31 2017)




Companies with similar Quick Ratio in the quarter ending Jun 30 2026, within Laboratory Analytical Instruments Industry Quick RatioJun 30 2026 MRQ Cash & cash equivalentJun 30 2026 MRQ Current Liabilities
Quanterix Corporation  1.86 $ 93.529  Millions$ 50.373  Millions
Nautilus Biotechnology Inc   1.52 $ 13.166  Millions$ 8.639  Millions
Rapid Micro Biosystems Inc   1.13 $ 20.500  Millions$ 18.150  Millions
Bionano Genomics Inc   1.04 $ 10.420  Millions$ 10.039  Millions
Bio rad Laboratories Inc   0.92 $ 886.900  Millions$ 961.300  Millions
Precipio inc   0.83 $ 3.075  Millions$ 3.701  Millions
Lifeloc Technologies Inc   0.83 $ 0.908  Millions$ 1.099  Millions
Agilent Technologies inc   0.77 $ 1,758.000  Millions$ 2,289.000  Millions
Revvity Inc  0.67 $ 1,022.943  Millions$ 1,516.157  Millions
Harvard Bioscience Inc   0.26 $ 6.503  Millions$ 24.793  Millions
Waters Corporation  0.22 $ 539.000  Millions$ 2,399.000  Millions
Kewaunee Scientific Corporation  0.22 $ 10.261  Millions$ 47.235  Millions
Bruker Corporation  0.18 $ 217.200  Millions$ 1,204.700  Millions

Date modified: 2026-09-08T21:43:35+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.